| Authors: |
Ogasawara A; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan; Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan., Suzuki S; Department of Gynecologic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Oda K; Department of Clinical Genomics, The University of Tokyo Hospital, Tokyo, Japan., Yunokawa M; Department of Gynecologic Oncology, The Cancer Institute Hospital of JFCR, Tokyo, Japan; Department of Advanced Medical Development, The Cancer Institute Hospital of JFCR, Tokyo, Japan., Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Mori M; Department of Gynecologic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Kurosaki A; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan., Mori M; Department of Obstetrics and Gynecology, The University of Tokyo Hospital, Tokyo, Japan., Kitano S; Department of Advanced Medical Development, The Cancer Institute Hospital of JFCR, Tokyo, Japan., Shintani D; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan., Saigusa Y; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan., Matsushita H; Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan., Takeda Y; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan., Hasegawa K; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan. Electronic address: koseih@saitama-med.ac.jp. |
